Skip to content
Clinical Trials – home

GYNORD plus s.r.o.

Research site

Czechia Slavnikovcu 231/7, Marianske Hory, 709 00 Ostrava, Czechia

  • 2 trials recruiting
  • Bacterial vaginosis · Stress · Urinary incontinence
  • Adult patients

About Specializations

GYNORD plus s.r.o. in Ostrava, Czechia specialises in clinical trials of conditions such as Bacterial vaginosis, Stress, Urinary incontinence, and other specialisations. This site conducts important research.

Main research areas of the site

Bacterial Infections and Mycoses

GYNORD plus s.r.o. conducts research on genital bacterial disorders, aiming to improve treatment options for women.

  • Evaluation of new antimicrobial agents for bacterial vaginosis
  • Comparative effectiveness of vaginal tablets versus creams
  • Monitoring resistance trends in female genital infections

The studies seek to show that the investigational product is at least as effective as standard therapy, enhancing care for patients with this condition.

Female Urogenital Diseases and Pregnancy Complications

The site is also active in trials addressing urinary continence problems, particularly in women with excess weight.

  • Testing oral agents for stress urinary incontinence
  • Analyzing the influence of obesity on continence outcomes
  • Measuring improvements in daily activity and quality of life

These investigations aim to demonstrate superior symptom reduction compared with placebo, offering new options for affected women.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Slavnikovcu 231/7, Marianske Hory709 00 OstravaCzechia
Recruiting now
2 trials
Conditions studied
3

More sites in OstravaCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Orforglipron for stress urinary incontinence in women with obesity or overweight

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Orforglipron hemicalcium
  • Sponsor:Eli Lilly & Co.

A study comparing furazidin and clindamycin for women with bacterial vaginosis

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Clindamycin Phosphate
  • Sponsor:Adamed Pharma S.A.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.